30 results on '"Gockerman, Jon P."'
Search Results
2. Phase I study of dose dense induction and consolidation with gemtuzumab ozogamicin and high dose cytarabine in older adults with AML
3. “Short Course” Bortezomib plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Nontransplant Candidates in Patients with Previously Untreated Multiple Myeloma
4. CLL cell apoptosis induced by nitric oxide synthase inhibitors: Correlation with lipid solubility and NOS1 dissociation constant
5. Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels
6. Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma
7. MINI01.02: Response and Plasma Genotyping from Phase I/II Trial of Ensartinib (X-396) in Patients (pts) with ALK+ NSCLC: Topic: Medical Oncology
8. Phase I/II trial of X-396, a novel anaplastic lymphoma kinase (ALK) inhibitor, in patients with ALK+ non-small cell lung cancer (NSCLC)
9. Malignant melanoma presenting as a mediastinal mass
10. Phase II Study of VEGF Inhibitor, PTK787/ZK222584, in Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma
11. Re-Induction Therapy Decisions Based on Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia,
12. High Complete Response Rates with Dose Dense/Dose Intense Chemotherapy Plus Radioimmunotherapy in High Risk Diffuse Large B Cell and Mantle Cell Lymphoma
13. Chronic Lymphocytic Leukemia Shares a Common Cellular Origin with Regulatory B10 Cells
14. Bortezomib Plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Non-Transplant Candidates in Patients with Previously Untreated Multiple Myeloma.
15. Family-Associated Monoclonal B Lymphocytosis Is Commonly Oligoclonal and Expresses Markers Associated with Adverse Risk in CLL
16. Apolipoprotein E-Mimetic Therapeutic Peptides Mediate CLL Cell Cytotoxicity
17. Cytotoxicity of the Type 4 Phosphodiesterase Inhibitor CD160130 for Freshly Isolated Human CLL Cells In Vitro.
18. A Genomic Strategy To Refine Prognosis and Predict Response to Therapy in Chronic Lymphocytic Leukemia.
19. Monoclonal B Cell Lymphocytosis as a Marker of Inherited Predisposition to Chronic Lymphocytic Leukemia.
20. Functional and Numerical T Cell Abnormalities in Chronic Lymphocytic Leukemia.
21. Monoclonal B Cell Lymphocytosis Exhibits Biologic Diversity Similar to Chronic Lymphocytic Leukemia.
22. Apolipoprotein E (APOE) Genotype as a Determinant of Survival in Women with Chronic Lymphocytic Leukemia.
23. Multimodal Dose Dense Therapy for Mantle Cell Lymphoma.
24. A Single Cell Analysis of Immunoglobulin Genes in Chronic Lymphocytic Leukemia (CLL): Evidence of Intraclonal Diversification Associated with Progressive Somatic Mutations and Progressive Antigen Drive in Immunoglobulin Heavy and Light Chains.
25. Dose Dense, High Intensity Induction Therapy Followed by Early High Dose Chemotherapy (HDT) and Autologous Hematopoietic Stem Cell Transplantation(AHSCT) for Mantle Cell Lymphoma (MCL).
26. Improved survival in advanced Hodgkin's disease with the use of combined modality therapy
27. Evidence for a selective antileukemic effect of cytosine arabinoside in chronic granulocytic leukemia
28. Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells
29. Purification and Characterization of Papain-Solubilized HLA Antigens From Human Platelets
30. Immune deficiency and expanded population of granular lymphocytes after bone marrow transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.